AndreasSchwingshacklMDPhD

Pediatric Critical Care Medicine

Assistant Professor, Pediatrics, University of California Los Angeles

Dr. Schwingshackl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Critical Care Medicine, 2006 - 2009
Barrow Neurological Institute at St Joseph's Hospital and Medical CenterResidency, Pediatrics, 2003 - 2006
Leopold Franzen University Innsbruck Faculty of MedicineClass of 1997

Dorothy & Robert Keyser Endowed Chair Children’s Discovery & Innovation Institute, 2017

PubMed

110 citations
Pulmonary epithelial barrier function: some new players and mechanisms.
Kieran Brune, James A. Frank, Andreas Schwingshackl, James H. Finigan, Venkataramana K. Sidhaye
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2015-04-15
26 citations
Hyperoxia treatment of TREK-1/TREK-2/TRAAK-deficient mice is associated with a reduction in surfactant proteins.
Andreas Schwingshackl, Benjamin Lopez, Bin Teng, Charlean L. Luellen, Florian Lesage
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2017-08-24
2 citations
Protection from acute lung injury by a peptide designed to inhibit the voltage-gated proton channel.
Ruiming Zhao, Benjamin Lopez, Andreas Schwingshackl, Steve A N Goldstein
Iscience. 2023-01-20

UC Irvine, UCLA Researchers Identify New Therapeutic Approach to Prevent ARDSJanuary 17th, 2023